CERS2 and breast cancer: As shown in Table 1, cross-referencing both databases suggests that the miRNAs miR-125b, miR-185, miR-205, miR-222, miR-30-3p, and miR-30c may owe their association with BC to their regulatory action on CERS2 and may be taken into account in future studies.